As a recognized serum biomarker for tumor diagnosis, GP73 is also highly expressed in tumors (20), where it boosts the expression and secretion of pro-inflammatory cytokines and vascular endothelial growth factor A (VEGFA) in tumor cells (21, 22). The gene discussed is VEGFA; the disease is neoplasm.